비응급 의료 운송 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00018286
  • Category : Healthcare IT
  • Status : Published
  • No. of Pages : 193
Buy Now

[연구보고서] 비응급 의료운송 시장은 2021년 86억 5,887만 달러에서 2028년 155억 7,998만 달러로 성장할 것으로 예상된다. 2022년부터 2028년까지 CAGR 9.0%로 성장할 것으로 예상됩니다.

비응급 의료 운송 시장은 서비스 유형, 애플리케이션 및 지역을 기준으로 분류됩니다. 이 보고서는 시장 동향 및 기회, 시장 역학, 다양한 지역의 주요 시장 플레이어에 대한 경쟁 환경 분석 등 다양한 매개변수를 강조하면서 시장에 대한 통찰력과 심층 분석을 제공합니다. 또한 지역 전반에 걸친 코로나19 팬데믹의 영향 분석도 포함됩니다.

시장 통찰력

만성 질환 발병률 증가

만성 질환이 절반 이상을 차지합니다. 전 세계 총 사망자 수. 질병통제예방센터(CDC)는 미국인 10명 중 6명이 심장병, 뇌졸중, 암, 당뇨병 등 적어도 한 가지 만성 질환을 앓고 있는 것으로 추정하고 있습니다. 만성 질환은 심혈관 질환과 암을 포함하여 미국에서 사망 및 장애의 주요 원인이며, 전체적으로 전체 사망의 약 38%를 차지합니다. 세계보건기구(WHO) 2021년 데이터에 따르면 전 세계적으로 매년 심혈관 질환으로 인한 사망자가 1,790만 명에 달하며, 암(930만 명), 호흡기 질환(410만 명), 당뇨병(150만 명)이 그 뒤를 따릅니다.

만성질환 환자의 반복되는 의료비에 대한 걱정 외에도, 가족들은 응급 상황 시 교통편을 마련하는 데 적극적으로 나서야 합니다. 이러한 환자들은 건강을 유지하기 위해 정기적으로 생명을 구하는 의료 서비스를 받아야 하기 때문입니다. 일부는 매일 치료가 필요할 수도 있지만 많은 경우 매주 상담을 위해 의사를 방문합니다. 특히 차량을 소유하지 않은 저소득층 가족의 경우 별도의 차량을 마련하는 것이 불가능할 수 있습니다. 그러한 경우 NEMT는 사람들에게 큰 도움이 되는 것으로 입증되었습니다. 연구에 따르면 약 2천만 명의 사람들이 투석을 위해 제때에 의료 시설에 가야 하는 만성 신장 질환을 앓고 있는 것으로 나타났습니다. 약속을 한 번 놓치면 병원에 긴급 입원하게 될 수도 있습니다. 그러한 환자들에게 NEMT의 가용성은 큰 도움이 됩니다. NEMT를 쉽게 이용할 수 있으므로 만성 질환을 앓고 있는 개인이 지체 없이 생명 유지 치료 및 건강 관리 서비스에 접근할 수 있습니다. NEMT는 교통 장애로 인해 약속을 놓치지 않고 약속 장소에 갈 수 있는 믿을 수 있는 방법이며 시장 성장을 촉진합니다.

전략적 통찰력

서비스 유형 – 기반 통찰력

서비스 유형에 따라 비응급 의료 운송 시장은 개인 유료 환자 운송, 보험 지원 환자 운송, 택배 서비스 등으로 분류됩니다. 2022년에는 민간 유료 환자 운송 부문이 가장 큰 시장 점유율을 차지했습니다. 또한, 동일한 부문은 2022~2028년 동안 시장에서 가장 높은 CAGR을 기록할 것으로 예상됩니다. 개인 유료 환자 교통 서비스는 환자가 진료소와 병원을 오가는 이동 및 약국 픽업을 위해 사용됩니다. 또한 Medicaid 회원이 아닌 사람들도 의료 관련 통근을 위해 이러한 서비스를 이용할 수 있습니다. 메디케어 및 민간 보험 정책에는 교통비가 포함되어 있지 않으며 환자는 NEMT 비용을 지불합니다. 개인 유료 환자 운송의 다양한 이점에는 다른 것보다 마진이 높은 맞춤형 NEMT 환급률, 정규 업무 시간 외에 사용량이 적은 시간에 이동하는 경향이 포함됩니다.

비응급 의료 운송 시장, by 서비스 유형 – 2021년–2028년

신청– 기반 통찰력

응급 상황에 따라 비응급 의료 운송 시장은 투석, 정기 의사 방문, 정신 건강 관련 예약, 재활 등으로 분류됩니다. 2022년에는 정신 건강 관련 약속 부문이 시장에서 가장 큰 점유율을 차지했습니다. 그러나 재활 부문 시장은 예측 기간 동안 가장 빠른 속도로 성장할 것으로 예상됩니다. 정신 건강 치료, 서비스, 지원을 받는 것은 정신 질환을 앓고 있는 사람들이 건강을 회복하고 유지하는 데 매우 중요합니다. 이 환자들은 법적으로 운송을 위해 차량을 사용할 수 없습니다. 따라서 진료 예약 장소를 오가는 신뢰할 수 있고 저렴한 교통 수단을 확보하는 것이 종종 NEMT 서비스 채택을 촉진하는 주요 장애물입니다. Oregon Health Plan(OHP)은 회원에게 약속 장소까지 무료 교통편을 제공합니다. 의료 방문, 정신 건강 서비스 및 OHP에 따른 기타 보장 서비스에 차량 서비스를 이용할 수 있습니다.

비응급 의료 운송 시장 참여자는 제품 출시 및 확장과 같은 유기적인 전략을 채택하여 확장합니다. 전 세계적으로 입지와 제품 포트폴리오를 확보하고 증가하는 수요를 충족합니다. 시장에서 목격되는 무기적 성장 전략은 파트너십과 협업이다. 이러한 성장 전략을 통해 시장 참가자는 비즈니스를 확장하고 지리적 입지를 강화할 수 있었습니다. 또한 인수, 파트너십 및 기타 성장 전략은 회사의 고객 기반을 강화하고 제품 포트폴리오를 늘리는 데 도움이 됩니다.

  • 2022년 6월, MTM, Inc .은 캘리포니아주 샌디에고에 본사를 둔 NEMT 회사인 Veyo를 인수하여 약 10억 달러의 연간 총 수익을 달성했습니다. 이제 이 조직은 31개 주와 컬럼비아 특별구의 1,600만 명에게 매년 2,000만 번의 여행을 제공하게 됩니다.
  • 2021년 6월 기술 기반 의료 서비스 회사인 Modivcare Inc.는 nuVizz, Inc.의 WellRyde 기술 사업 인수. WellRyde는 최적화된 경로 지정, 자동화된 이동 할당 및 청구, 실시간 네트워크 모니터링을 지원하는 첨단 교통 관리 시스템(ATMS) 소프트웨어 분야의 선도적인 기술 제공업체입니다. WellRyde 솔루션은 1,200개가 넘는 운송 제공업체에서 사용됩니다.
  • 2021년 4월, MTM, Inc.는 Medicaid와 수도권의 지적 및 발달 장애인(IDD) 수혜자에게 고품질 NEMT 서비스를 제공했습니다. 워싱턴, 유효기간은 14년. 컬럼비아 특별구는 MTM을 NEMT 브로커로 선택했으며 새 계약 기간은 1년 + 추가 옵션 4년입니다.

회사 프로필

  • ABC 비응급 의료 운송, LLC
  • MTM, Inc.
  • AMR
  • Xpress Transportation
  • CJ Medical Transportation
  • < li>Southeastrans
  • Modivcare
  • Crothall Healthcare
  • Elite Medical Transport
  • Acadian Ambulance Service
  • ERS Transition Ltd .
  • Global Rescue LLC.
  • London Medical Transportation Systems
  • FirstGroup PLC
  • Transdev
  • Ride Health< /li>
  • 왕복
  • Medical Answering Services, LLC
  • 한 번의 통화
  • Kinetik
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is non-emergency medical transportation?

Non-emergency medical transportation is a medical transportation service provided to persons who require medical attention but do not have a critical (i.e., serious) health condition. Non-emergency medical transportation is usually reserved for the elderly or those who are physically or mentally challenged. Non-emergency medical transportation can be picked up and dropped off for free or for a fee. This mode of transportation is used frequently for checkups, scans, OPD visits, and pathology testing, among others.

What are the driving factors for the global non-emergency medical transportation market across the world?

The factors that are driving the growth of market are growing need for non-emergency medical transportation, rising incidence of chronic disease, and increasing geriatric population. However, lack of efficient oversight systems and fraud by NEMT companies and lack of services in rural areas are major factor hindering the non-emergency medical transportation market growth.

What will be the CAGR of the non-emergency medical transportation market during the forecast period?

The market is estimated to grow at a CAGR of 9.0% during the forecast period.

What are the growth estimates for the non-emergency medical transportation market till 2028?

The non-emergency medical transportation market is expected to be valued at US$ 15,579.98 million in 2028.

What is the estimated non-emergency medical transportation market size in 2021?

The non-emergency medical transportation market is estimated to be valued at US$ 8,658.87 million in 2021.

Who are the major players in non-emergency medical transportation market across the world?

The non-emergency medical transportation market majorly consists of the players, such as ABC Non-Emergency Medical Transportation, LLC; MTM, Inc.; AMR; Xpress Transportation; CJ Medical Transportation; Southeastrans; ModivCare; Crothall Healthcare; Elite Medical Transport; Acadian Ambulance Service; ERS Transition Ltd.; Global Rescue Ltd; London Medical Transportation System; Transdev; Medical Answering Services, LLC; Roundtrip; One Call, Kinetik; Ride Health; and FirstGroup, plc. among others.

Which segment is dominating the non-emergency medical transportation market based on service type?

The non-emergency medical transportation market is analyzed based on service type and application. Based on service type, the market is segmented into private pay patient transportation, insurance backed patient transportation, courier services, and others. In 2022, the private pay patient transportation segment held the largest share of the market. Moreover, the same segment is anticipated to register the highest CAGR in the forecast period.

Which region accounts for major market share in 2022 in global non-emergency medical transportation market?

North America accounts for the major market share of non-emergency medical transportation market in 2022 due to increasing aging population and rising prevalence of chronic illnesses.

Which region is projected to be the fastest growing region in the global non-emergency medical transportation market?

Asia Pacific is expected to be the fastest growing region in non-emergency medical transportation market over the forecast period due to increased healthcare spending and rising awareness about NEMT solutions.

The List of Companies - Non-Emergency Medical Transportation Market

  1. ABC NON-EMERGENCY MEDICAL TRANSPORTATION, LLC
  2. MTM, INC.
  3. AMR
  4. XPRESS TRANSPORTATION
  5. CJ MEDICAL TRANSPORTATION
  6. SOUTHEASTRANS
  7. MODIVCARE
  8. CROTHALL HEALTHCARE
  9. ELITE MEDICAL TRANSPORT
  10. ACADIAN AMBULANCE SERVICE

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports